| Literature DB >> 30090431 |
I Miller1, C Diepenbroek2, E Rijntjes2,3, J Renaut4, K J Teerds2, C Kwadijk5, S Cambier4, A J Murk6, A C Gutleb4, T Serchi4.
Abstract
The influence of short term (7-day) exposure of male rats to the brominated flame retardant hexabromocyclododecane (HBCD) was studied by investigation of the liver proteome, both in euthyroid and hypothyroid rats and by comparing results with general data on animal physiology and thyroid hormone, leptin, insulin and gonadotropin concentrations determined in parallel. Proteome analysis of liver tissue by two-dimensional fluorescence difference gel electrophoresis (2D-DIGE) revealed that only small protein pattern changes were induced by exposure in males, on just a few proteins with different functions and not involved in pathways in common. This is in contrast to previous findings in similarly exposed eu- and hypothyroid female rats, where general metabolic pathways had been shown to be affected. The largest gender-dependent effects concerned basal concentrations of liver proteins already in control and hypothyroid animals, involving mainly the pathways which were also differently affected by HBCD exposure. Among them were differences in lipid metabolism, which - upon exposure to HBCD - may also be the reason for the considerably higher ratio of γ-HBCD accumulated in white adipose tissue of exposed female rats compared to males. The results further elucidate the already suggested different sensitivity of genders towards HBCD exposure on the protein level, and confirm the need for undertaking toxicological animal experiments in both genders.Entities:
Year: 2016 PMID: 30090431 PMCID: PMC6062380 DOI: 10.1039/c6tx00166a
Source DB: PubMed Journal: Toxicol Res (Camb) ISSN: 2045-452X Impact factor: 3.524
Animal data (males): animals were exposed to 0, 3, or 30 mg per kg bw per d for 7 days
| HBCD-group | 0 | 3 | 30 | Thyroid effect ( | HBCD effect ( | Interaction ( | Spearman's Rho | |
| Body weight (g) | ET | 427 ± 36 | 428 ± 35 | 430 ± 27 | <0.001 | 0.828 | 0.736 | –0.045 |
| HT | 165 ± 22 | 153 ± 45 | 146 ± 32 | –0.272 | ||||
| Liver weight (g) | ET | 16.30 ± 1.12 | 16.14 ± 1.93 | 16.44 ± 1.68 | <0.001 | 0.867 | 0.766 | 0.058 |
| HT | 5.49 ± 0.80 | 5.12 ± 1.71 | 4.78 ± 1.11 | –0.295 | ||||
| TSH (ng ml–1) | ET | 0.38 ± 0.34 | 1.27 ± 0.92 | 0.49 ± 0.27 | <0.001 | 0.810 | 0.409 | 0.168 |
| HT | 17.01 ± 5.06 | 14.51 ± 4.31 | 16.76 ± 4.40 | –0.012 | ||||
| Total T4 (μg dl–1) | ET | 4.4 ± 0.3 | 3.9 ± 0.8 | 4.2 ± 0.5 | <0.001 | 0.189 | 0.229 | –0.306 |
| HT | <lod | <lod | <lod | 0.433 | ||||
| Total T3 (ng ml–1) | ET | 230 ± 48 | 234 ± 41 | 196 ± 9 | <0.001 | 0.189 | 0.587 | –0.35 |
| HT | 165 ± 12 | 177 ± 25 | 161 ± 47 | –0.148 | ||||
| Free T3 (pg ml–1) | ET | 5.95 ± 0.51 | 6.30 ± 0.61 | 5.27 ± 0.87 | <0.001 | 0.044 | 0.326 | –0.341 |
| HT | 1.56 ± 0.31 | 2.39 ± 0.78 | 1.80 ± 0.60 | 0.041 | ||||
| LH (ng ml–1) | ET | 0.61 ± 0.15 | 1.22 ± 0.51 | 0.88 ± 0.30 | 0.002 | 0.021 | 0.088 | 0.33 |
| HT | 0.54 ± 0.18 | 0.62 ± 0.28 | 0.55 ± 0.13 | 0.018 | ||||
| FSH (ng ml–1) | ET | 3.81 ± 0.43 | 5.04 ± 0.80 | 4.00 ± 0.83 | 0.065 | 0.039 | 0.491 | 0.161 |
| HT | 3.72 ± 1.15 | 4.16 ± 1.75 | 2.91 ± 0.83 | –0.359 | ||||
| Testosterone (ng ml–1) | ET | 2.23 ± 1.93 | 1.09 ± 0.36 | 1.24 ± 0.42 | 0.645 | 0.751 | 0.217 | –0.308 |
| HT | 0.98 ± 0.65 | 1.35 ± 1.45 | 1.64 ± 1.54 | 0.233 | ||||
| Leptin (ng ml–1) | ET | 8 ± 2 | 7 ± 2 | 8 ± 2 | 0.006 | 0.205 | 0.134 | 0.022 |
| HT | 13 ± 4 | 12 ± 4 | 8 ± 4 | –0.428 | ||||
| Insulin (ng ml–1) | ET | 6.02 ± 1.92 | 5.18 ± 2.69 | 8.81 ± 3.77 | <0.001 | 0.174 | 0.035 | 0.261 |
| HT | 4.38 ± 2.08 | 2.26 ± 1.48 | 2.09 ± 0.81 | –0.613** | ||||
| Corticosterone (ng ml–1) | ET | 149 ± 71 | 103 ± 62 | 222 ± 69 | 0.027 | 0.056 | 0.549 | 0.35 |
| HT | 183 ± 46 | 242 ± 113 | 353 ± 260 | 0.193 | ||||
| Internal γ-HBCD (mg per kg lw) | ET | <lod | 25.5 ± 5.2 | 81.0 ± 33.1 | 0.002 | <0.001 | 0.013 | |
| HT | <lod | 40.7 ± 8.6 | 130.0 ± 32.9 |
Fig. 1Two-dimensional gel image of a rat liver sample: 2D-DIGE separation of rat liver sample (master gel, grey level image). Marked spots show statistically significant changes in abundance upon HBCD exposure: 2 in mET animals (white squares), 6 in mHT rats (white triangles). In addition, 8 spots are of different abundance in ET and HT males (6 white diamonds + spots #1165, #1376 with other symbols). Detailed data on identifications is compiled in ESI Table 2.†
Comparison of HBCD-treated male rats
| Significant changes | |||||||||||
| (a) Effect of HBCD in ET-animals | |||||||||||
| Spot number | Protein name | UniProt ID | mET3/mET0 | mET30/mET0 | mET30/mET3 | Keywords/GO | Keywords/GO | Keywords/GO | |||
| Av. Ratio |
| Av. Ratio |
| Av. Ratio |
| Biological process | Cellular component | Molecular function | |||
| 1165 | rCG56002 | 0.877 | 0.548 | 1.310 | 0.135 | 1.490 | 0.0189 | ||||
| 1413 | Small glutamine-rich tetratricopeptide repeat-containing protein alpha | SGTA_RAT | 0.980 | 0.897 | 1.270 | 0.0527 | 1.300 | 0.00644 | Binds directly to HSC70 and HSP70 and | Cytoplasm | Chaperone |
Fig. 2PCA of proteomic data: PCA of the 496 differentially regulated protein spots: (A) comparison of experimental groups (score plot), (B) comparison of all proteins (loading plot).
Fig. 3Spot differences between genders: numbers of spots or proteins with altered abundance between male and female controls, as a table and Venn diagram (for proteins).
Fig. 4Pathway analysis (STRING): networks created from proteins differentially regulated in male and female rats (controls) in ET animals (A) or HT rats (B). Members from pathways related to Glycolysis/Gluconeogenesis (Glyco), Fatty acid metabolism (FA), Drug metabolism or Metabolism of xenobiotics by cytochrome P450 (CYP), Glutathione metabolism (GSH) are boxed. Boxes are displayed in colour. Further details on pathways and gene/protein names are compiled in ESI Table 3.†